In-principle approval for preferential share swap of 8.05 million shares
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anlon Healthcare received in-principle approval from NSE and BSE for a proposed preferential issue of 8,05,35,651 equity shares of Rs 2 each through a share swap. The approval letters are dated October 28, 2026. The filing does not disclose the issue price, investor name or final completion details.
The proposed swap may dilute existing shareholders if completed. Final issue terms and completion approvals remain pending.